A Key Novartis Drug Could Be Delayed — Why This Stock Is Cheering

A Key Novartis Drug Could Be Delayed — Why This Stock Is Cheering

Submitted by admin on October 5, 2019 - 2:17pm
Source: 
Investors Business Daily
News Tags: 
Coherus Biosciences
Novartis
Udenyca
Neulasta
biosmilars
Headline: 
A Key Novartis Drug Could Be Delayed — Why This Stock Is Cheering
snippet: 

Coherus Biosciences (CHRS) shares popped Friday on the possibility of delays for a rival drug from Novartis (NVS). On today's stock market, Coherus stock jumped 5.1%, to 20.99.

Do Not Allow Advertisers to Use My Personal information